PlainRecalls
FDA Drug Moderate Class II Terminated

L-Cysteine Hydrochloride Injection, USP, 0.5 g/10 mL (50 mg/mL), 10 mL Single Dose Vial (NDC 66758-004-01), packaged in 10 x 10mL Vials per carton (NDC 66758-004-02), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.

Reported: November 23, 2016 Initiated: November 9, 2016 #D-0140-2017

Product Description

L-Cysteine Hydrochloride Injection, USP, 0.5 g/10 mL (50 mg/mL), 10 mL Single Dose Vial (NDC 66758-004-01), packaged in 10 x 10mL Vials per carton (NDC 66758-004-02), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.

Reason for Recall

Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that the product sterility may be compromised.

Details

Recalling Firm
Sandoz Inc
Units Affected
18,751 vials
Distribution
Nationwide throughout the USA
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
L-Cysteine Hydrochloride Injection, USP, 0.5 g/10 mL (50 mg/mL), 10 mL Single Dose Vial (NDC 66758-004-01), packaged in 10 x 10mL Vials per carton (NDC 66758-004-02), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.. Recalled by Sandoz Inc. Units affected: 18,751 vials.
Why was this product recalled?
Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that the product sterility may be compromised.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 23, 2016. Severity: Moderate. Recall number: D-0140-2017.